《大行報告》瑞銀下調潤啤(00291.HK)目標價至70元 評級「買入」
瑞銀髮表報告指,華潤啤酒(00291.HK)去年純利爲45.87億元人民幣,符合早前的盈利預告指引。但公司去年下半年毛利率按年下跌3個百分點,及去年高端產品業務增長28%,均低於指引。
該行表示,爲反映華潤啤酒去年業績及今年的管理層指引,決定將華潤啤酒2022年至2024年核心盈利及每股盈利預測平均下調5%。
瑞銀稱下調對華潤啤酒目標價由72.7元降至70元,此相當於預測2023年企業價值對EBITDA的20倍,維持「買入」評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.